Brooks Instrument Joins Major Biotechnology Consortium Focused on Regenerative Drug Manufacturing

Brooks Instrument will contribute insights and precision fluid control technology to the Advanced Regenerative Manufacturing Institute’s BioFabUSA program

11-Aug-2023 - USA

Brooks Instrument has joined the Advanced Regenerative Manufacturing Institute (ARMI) and will be an active participant in the organization’s BioFabUSA program.

ARMI is a member-based, nonprofit entity whose mission is to expand the bioeconomy of the United States. Through its programs, ARMI intends for its work to positively impact not only biomanufacturing but also healthcare. Within ARMI, the BioFabUSA program is focused on developing a highly diverse, competitive, capable and innovative cell, tissue and organ manufacturing ecosystem in the U.S.

Brooks Instrument offers advanced fluid measurement and control technologies used in life science applications.

Brooks Instrument joined the ARMI BioFabUSA program to contribute its expertise, product knowledge and experience in helping biotech equipment manufacturers control the flow of critical process materials and gasses to maximize yield when growing tissue.

The BioFabUSA public-private partnership has more than 170 members representing industry, academia, government and nonprofit organizations. Through this program, its members transform tissue engineering and regenerative medicine research into an industry that delivers tissues and organs to people in need.

“As a member of BioFabUSA, Brooks Instrument is looking forward to collaborating, sharing capabilities and delivering the flow control systems that are necessary for a scalable, consistent and cost-effective cell manufacturing supply chain,” said Joseph Sipka, Business Development Director at Brooks Instrument.

https://www.analytica-world.com/en/news/1181301/brooks-instrument-joins-major-biotechnology-consortium-focused-on-regenerative-drug-manufacturing.html